We are traveling the bottom of the channel. I think it starts to move up shortly. Adolescent and Pediatric fixed dose phase 3 trials start this month and next month. FDA approval submission early/mid next year. Billion-dollar drug if it can get some funding? This is my own opinion, and you should not take any of this as financial advice.
Note
Curious what this would mean for the current producers of such meds like JNJ, PFE, NVS? I'm assuming they would buy out Cingulate quickly before something like that dented their sales.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.